59th Session of Commission on Narcotic Drugs inaugurated in Vienna

Mar 15, 2016 17:51 IST

The 59th Session of Commission on Narcotic Drugs (CND) was inaugurated on 14 March 2016 in Austria’s capital Vienna.

The 9-day long session seeks to promote a comprehensive understanding of the world drug problem and evolve appropriate strategies to deal with it.

Around 1500 delegates representing Member States, inter-governmental organizations, and civil society will be participating in the session.

During the session, the Commission will discuss 10 draft resolutions and hold 74 side events and over 25 exhibitions.

Among other things, the session’s work includes preparations for the UN General Assembly Special Session on the World Drug Problem (UNGASS 2016) to be held in April 2016.

The focus of the UNGASS 2016 will be on what actions Member States can take by 2019 to achieve the goals set forth in a policy document titled - Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem.

The draft outcome document for the UNGASS is expected to be written at the this session.

About Commission on Narcotic Drugs

• It was established by the Economic and Social Council (ECOSOC) in 1946, to assist the ECOSOC in supervising the application of the international drug control treaties.

• In 1991, the General Assembly further expanded the mandates of the CND to enable it to function as the governing body of the United Nations Office on Drugs and Crime (UNODC).

• It is also mandated to approve the budget of the Fund of the United Nations International Drug Control Programme, which accounts for over 90 per cent of the resources available to the United Nations for drug control.

• As per the UNODC, some 27 million people suffer from drug use disorders worldwide that include 12 million people who inject drugs.

Now get latest Current Affairs on mobile, Download # 1  Current Affairs App

Is this article important for exams ? Yes3 People Agreed

DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK